Stem Cell Therapy Promising in Progressive MShttp://www.medscape.com/viewarticle/757809
Results of a small proof-of-concept study hint that autologous mesenchymal stem cells may have neuroprotective effects in multiple sclerosis (MS).
The study involved 10 patients with secondary progressive MS and objective evidence of optic nerve involvement resulting from demyelination. Over the course of 6 to 10 months after a single infusion of autologous mesenchymal stem cells in the central nervous system (CNS), researchers saw evidence of functional, neurophysiological, and structural improvement in vision without evidence of significant adverse effects.
The patients also experienced a reduction in functional disability, as measured by the Expanded Disability Status Score (EDSS)...